Bookmark and Share

BioActivity Data for Compound Vinblastine (CID 5388983)

BioActivity Outcomes:
Active(231)
 
 
Inactive(792)
 
 
Inconclusive(122)
 
 
Unspecified(76)
 
 
Top Targets:
7tm 4(42)
 
 
NR LBD PPAR(16)
 
 
 
 
NR LBD ER(14)
 
 
 
NR LBD AR(14)
 
 
 
 
Tryp SPc(11)
 
 
BioAssay Types:
Screening(540)
 
 
 
 
Confirmatory(435)
 
 
 
 
 
Literature(160)
 
 
 
 
 
Summary(56)
 
 
 
 
BioAssay Categories:
In vitro(8)
 
 
 
In vivo(3)
 
 
 
Biochemical(135)
 
 
 
 
Toxicity(64)
 
 
 
 
 
ADME(18)
 
 
 
Cell-based(284)
 
 
 
 
 
Organism-base..(15)
 
 
BioActivity Types:
Potency(346)
 
 
 
 
 
IC50(121)
 
 
 
 
 
AC50(32)
 
 
 
 
 
EC50(13)
 
 
 
 
Data download

Chemical Probe    Active    Inactive    Inconclusive    Unspecified   

Total Bioassays: 991    Data Row: 1221   Total Pages: 62   Display: Page     
Sort: [Click the result table header to sort]
#SubstanceActivityBioAssayTargetLinks
OutcomeTypeValue [μM]
1
[SID103496250]
IC50 0.00032Antiplasmodial activity against Plasmodium falciparum W2 after 72 hrs by SYBR green assay [AID524796, Type: Literature]
View
2
[SID103496250]
IC50 0.00052Antiplasmodial activity against Plasmodium falciparum 3D7 after 72 hrs by SYBR green assay [AID524790, Type: Literature]
View
3
[SID170464977]
AC50 (uM) 0.0009qHTS Assay for Identifying Compounds that block Entry of Ebola Virus, Screen 1 blue channel [AID1117301, Type: confirmatory]
View
4
[SID103496250]
IC50 0.00093Antiplasmodial activity against Plasmodium falciparum Dd2 after 72 hrs by SYBR green assay [AID524793, Type: Literature]
View
5
[SID103496250]
IC50 0.00093Antiplasmodial activity against Plasmodium falciparum GB4 after 72 hrs by SYBR green assay [AID524794, Type: Literature]
View
6
[SID103496250]
IC50 0.001Antiplasmodial activity against Plasmodium falciparum HB3 after 72 hrs by SYBR green assay [AID524795, Type: Literature]
View
7
[SID170464976]
IC50 0.001RKO viability from Cell TiterGlo-IC50 [AID1117322, Type: confirmatory]
View
8
[SID170464977]
IC50 0.001RKO viability from Cell TiterGlo-IC50 [AID1117322, Type: confirmatory]
View
9
[SID170464976]
IC50 0.001SNU-C1 viability from Cell TiterGlo-IC50 [AID1117323, Type: confirmatory]
View
10
[SID170464977]
IC50 0.001HCT116 viability from Cell TiterGlo-IC50 [AID1117332, Type: confirmatory]
View
11
[SID170464976]
IC50 0.001Colo320 viability from Cell TiterGlo-IC50 [AID1117334, Type: confirmatory]
View
12
[SID170464977]
IC50 0.001Colo320 viability from Cell TiterGlo-IC50 [AID1117334, Type: confirmatory]
View
13
[SID170464976]
IC50 0.001HT-29 viability from Cell TiterGlo-IC50 [AID1117330, Type: confirmatory]
View
14
[SID170464977]
IC50 0.001HT-29 viability from Cell TiterGlo-IC50 [AID1117330, Type: confirmatory]
View
15
[SID170464976]
IC50 0.001GSK3B-pretreated HCT116 viability from Cell TiterGlo-IC50 [AID1117339, Type: confirmatory]
View
16
[SID170464977]
IC50 0.001GSK3B-pretreated HCT116 viability from Cell TiterGlo-IC50 [AID1117339, Type: confirmatory]
View
17
[SID103496250]
IC50 0.001Antiproliferative activity against human K562 cells after 48 hrs by hemocytometer [AID611267, Type: Literature]
View
18
[SID103496250]
IC50 0.001Antiproliferative activity against human K562 cells after 48 hrs by hemocytometric analysis [AID605844, Type: Literature]
View
19
[SID103496250]
IC50 0.001Cell growth inhibition of human K562 cells after 48 hrs [AID494520, Type: Literature]
View
20
[SID103496250]
IC50 0.001Antiproliferative activity against human K562 cells after 48 hrs [AID494501, Type: Literature]
View